Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer.

Pradhan, Rajesh; Dey, Anuradha; Taliyan, Rajeev; Puri, Anu; Kharavtekar, Sanskruti; Dubey, Sunil Kumar

Pradhan, Rajesh; Dey, Anuradha; Taliyan, Rajeev; Puri, Anu; Kharavtekar, Sanskruti; Dubey, Sunil Kumar.

Afiliação

Pradhan R; Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333031, India.
Dey A; Medical Research, R&D Healthcare Division, Emami Ltd., Kolkata 700056, India.
Taliyan R; Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333031, India.
Puri A; RNA Structure and Design Section, RNA Biology Laboratory (RBL), Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, USA.
Kharavtekar S; Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333031, India.
Dubey SK; Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333031, India.

Pharmaceutics ; 15(1)2023 Jan 11.

Article em En | MEDLINE | ID: mdl-36678877

Palavras-chave

biological barriers; inorganic nanoparticles; nano-therapeutics; organic nanoparticles; organic-inorganic hybrid nanoparticle; triple-negative breast cancer; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google